This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: Desentum Oy. Active years: 2018.
Company Filing History:
Years Active: 2018
Title: The Innovative Contributions of Heidi Holkeri
Introduction
Heidi Holkeri is a prominent inventor based in Espoo, Finland. She has made significant strides in the field of biotechnology, particularly in developing solutions for allergy desensitization. Her work focuses on creating hypoallergenic proteins that can help individuals suffering from birch pollen allergies.
Latest Patents
Heidi Holkeri holds a patent for her invention titled "Hypoallergen." This innovative patent provides mutant polypeptides that are useful as hypoallergens. More specifically, it includes mutant Bet v 1 proteins and their application in desensitizing individuals against birch pollen allergies. The invention also encompasses vaccine formulations that utilize these polypeptides, along with methods for vaccination against birch pollen allergy.
Career Highlights
Heidi is associated with Desentum Oy, a company dedicated to advancing allergy treatments. Her work at Desentum Oy has positioned her as a key player in the development of novel therapeutic approaches for allergy sufferers. With her expertise, she has contributed to the growing body of knowledge in the field of immunology.
Collaborations
Heidi collaborates with notable colleagues, including Kristiina Takkinen and Hans Söderlund. Their combined efforts enhance the research and development initiatives at Desentum Oy, fostering innovation in allergy treatment solutions.
Conclusion
Heidi Holkeri's contributions to the field of biotechnology, particularly in hypoallergenic solutions, demonstrate her commitment to improving the quality of life for allergy sufferers. Her innovative work continues to pave the way for advancements in allergy desensitization therapies.